# Pulse Biosciences (PLSE) — News

PLSE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/plse/news

## Recent headlines

- [Pulse Biosciences announces commercial and clinical partnership with the Clayman Thyroid Center](https://www.ainvest.com/news/pulse-biosciences-announces-commercial-clinical-partnership-clayman-thyroid-center-2610) — AInvest Wire, Oct 14, 2026
- [Pulse Biosciences Inc.: Oppenheimer raises target price to $60 from $35](https://www.ainvest.com/news/pulse-biosciences-oppenheimer-raises-target-price-60-35-2610) — AInvest Wire, Oct 13, 2026
  Oppenheimer & Co. has raised its price target for Pulse Biosciences Inc. (PULS) to $60 from $35, reflecting a more optimistic outlook on the company’s growth potential and market positioning. The adjustment comes amid ongoing developments in the biotechnology sector and increased investor interest…
- [Pulse Biosciences Inc: Canaccord Genuity raises target price to $58 from $43](https://www.ainvest.com/news/pulse-biosciences-canaccord-genuity-raises-target-price-58-43-2610) — AInvest Wire, Oct 6, 2026
  Canaccord Genuity has revised its price target for Pulse Biosciences Inc (NASDAQ:PLSE), raising it to $58 from $43, reflecting a positive outlook on the company’s potential performance. The updated target suggests increased confidence in the firm’s strategic direction and market positioning. Pulse…
- [Pulse Biosciences - Terminates TD Cowen distribution agreement on Sept 14, 2026 with $1 mln unsold - SEC filing](https://www.ainvest.com/news/pulse-biosciences-terminates-td-cowen-distribution-agreement-sept-14-2026-1-mln-unsold-sec-filing-2609) — AInvest Wire, Sep 15, 2026
  Pulse Biosciences, Inc. (NASDAQ: PLSE) has filed with the U.S. Securities and Exchange Commission (SEC) to terminate its at-the-market (ATM) equity distribution agreement with TD Cowen, effective September 14, 2026. At the time of termination, approximately $1 million remained unsold of the $59.98…
- [Pulse Biosciences - Enters equity distribution agreement with Mizuho for up to $85 mln - SEC filing](https://www.ainvest.com/news/pulse-biosciences-enters-equity-distribution-agreement-mizuho-85-mln-sec-filing-2609) — AInvest Wire, Sep 15, 2026
  Pulse Biosciences, Inc. (PLSE) has entered into an equity distribution agreement with Mizuho Securities USA LLC to sell up to $75 million of its common stock through at-the-market offerings under an existing shelf registration, according to a recent SEC filing. Under the terms of the agreement,…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).